Medichem Uses Corning Reactor In Continuous Flow API Production

By Chemical Processing Staff

Feb 05, 2015

Corning Incorporated and Medichem S.A. successfully demonstrated a commercial scale, continuous-flow production of active pharmaceutical ingredients (APIs) using the Corning Advanced-Flow G4 silicon carbide reactor.

Medichem produced an organometallic compound API under cGMP conditions in several production campaigns and can now repeat its results with a continuous flow multipurpose unit at industrial scale. Corning’s equipment solution includes automated feeding systems that comply with the ATEX directive and G4 reactor.

For more information, visit:

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments